Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
10 Apr - 12 Jun 1979
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Principles of method if other than guideline:
BASF-Test: The study was conducted according to an internal BASF method which in principle is comparable to the OECD Guideline 401.
GLP compliance:
no
Remarks:
Did not exist at that time
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Ethylenediamine
EC Number:
203-468-6
EC Name:
Ethylenediamine
Cas Number:
107-15-3
Molecular formula:
C2H8N2
IUPAC Name:
ethane-1,2-diamine
Details on test material:
- Name of test material (as cited in study report): Ethylendiamine
- Analytical purity: 99 %

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: male: 230 g (mean); female: 188 g (mean)
- Fasting period before study: 15 - 20 h before administration
- Diet (e.g. ad libitum): Herlian MRH, Eggersmann KG

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 3.16 - 14.70 %

MAXIMUM DOSE VOLUME APPLIED: 10 ml

Doses:
316, 464, 681, 825, 1000, 1210, 1470 mg/kg
No. of animals per sex per dose:
316, 464, 681 mg/kg: 5
825, 1000, 1210, 1470 mg/kg: 10
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Frequency of weighing: days 0, 3, 7, 13
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
Not required for this type of study

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD50
Effect level:
866 mg/kg bw
95% CL:
762 - 946
Sex:
male
Dose descriptor:
LD50
Effect level:
841 mg/kg bw
95% CL:
683 - 943
Sex:
female
Dose descriptor:
LD50
Effect level:
893 mg/kg bw
95% CL:
750 - 943
Mortality:
1470 mg/kg: all animals died within 24 h
1210 mg/kg: 8 males and females each died within 24 h. 1 further male died within 48 h.
1000 mg/kg: 7 males and 6 females died within24 h. 1 further male and female died within 48 h.
825 mg/kg: 5 males and females each died within 24 h. 1 further male died within 48 h.
681, 464, 316 mg/kg: no mortality occured.
Clinical signs:
other: See detailed table in remarks on results.
Body weight:
other body weight observations
Remarks:
See detailed table in remarks on results
Gross pathology:
Dead animals:
Heart: acute dilatation on the right side; acute congestion;
Stomach: diffuse reddening of the glandular stomach;
Intestine: in individual animals diarrhoeic content; atonic; reddened in several cases;
Liver: in some animals individual focal necrosis;
Thymus: in individual animals extensive hemorrhages.

Sacrificed animals:
Stomach: in several animals wall of the forestomach slightly indurated. In individual cases adhesion of the forestomach to the liver.

Any other information on results incl. tables

Mortality:


 




































































































 Dose (mg/kg) 1 h    24 h    48 h    14 days   
  male femalemale  female male female male female
 1470 0/10 0/10 10/10 10/10 10/1010/10 10/10 10/10 
1210 0/100/10 8/10 8/10 9/10 8/10 9/10 8/10
 1000 0/10 0/10 7/10 6/10 8/10 7/10 8/10 7/10
  825 0/10 0/10 5/10 5/10 6/10 5/10 6/10 5/10
  681 0/5 0/5 0/50/5 0/5  0/5 0/5 0/5
  464 0/5 0/50/5  0/5 0/5 0/5 0/5 0/5
  316 0/5 0/5 0/5 0/5 0/50/5 0/5  0/5

 


Mean weight (g):


 












































































































































 Dose (mg/kg) gender day 0 day 2-4 day 7 day 13 
 1470 male140154196235 
  female175 - - - 
 1210 male220 200234271 
  female190195212226 
 1000 male250221   247  281  
  female195175  186  204  
 825 male 220 214  230  271  
  female190 166  192  212  
 681 male300298327349 
  female210212227205 
 464 male300305340370 
  female220226240   249  
 316 male180205244 290 
  female160172189204 

 


Clinical signs: symptoms occured in the indicated time:


 





































































































































































 Dose  1470 mg/kg 1210 mg/kg 1000 mg/kg 825 mg/kg 681 mg/kg 464 mg/kg 316 mg/kg
 Dyspnea 15 min - 5 h - 1 d- 1 d 15 min - 1 d 30 min - 5 h 5 h -
 Spasmodic respiration - 15 min - 4 h 2 h - 4 h 2 h - - -
 Apathy 15 min - 1d - 1 d - 3 d 15 min - 3 d 15 min - 5 h 1 h - 5 h -
 Abnormal position 5 h - -  - -   - -
 Staggering 15 min - 5 h - 4 h  15 min - 1 d 15 min - 1 d 15 min - 1 d 1 h - 5 h -
 Spastic gait 15 min - 1 d - 1 d15 min - 3 d 15 min - 3 d 15 min - 1 d 1 h - 1 d -
 Urine (orange/yellow) - 1 d - 2 d 4 h - 3 d 1 d - 3 d 4 h - 3 d 4 h - 1 d -
 Piloerection 30 min - 2 d - 1 d 30 min - 3 d  15 min - 3 d 1 h - 5 h 2 h - 5 h -
 Diarrhea 4 h - 5 h 4 h - 1 d 4 h - 1 d 2 h - 1 d 4 h - 1 d 4 h - 5 h -
 Cyanosis 2 h - 4 h - - -  - - -
 Exsiccosis 4 h 4 h - 1 d 1 d 2 h - 1 d - - -
 Salivation -  - 2 h - 4 h - - - -
 Blood in feces - - 5 h - 5 h 5 h -
 Poor general condition 15 min - 1 d - 1 d - 3 d 15 min - 3 d 15 min - 1 d1 h - 5 h  -
        

min: minute; h: hour; d: day


 


There is an indication that the test substance causes local irritation to exposed tissues.

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
The combined LD50 value in an acute oral toxicity test to rats was 866 mg/kg bw.
Executive summary:

In an acute toxicity test on rats, test groups consisting of 5 animals/sex was treated by single gavage application with an aqueous solution of the test substance. The animals were observed for mortality and for clinical symptoms of toxicity. They were weighed prior treatment and thereafter, day 3, day 7 and day 13 post-treatment. At the end of the observation period of 14 days, the surviving animals were sacrificed for the purpose of necropsy; animals that died during the observations period also were subjected to necropsy. A combined (males/females) LD50 value of 866 mg/kg was estimated on the basis of the observed mortalities.